19 Mayis University Medical Faculty

Samsun 55139

0 studies enrolling now · 2 studies all time

What they study most

Estrogen Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer, Urothelial Carcinoma

Studies at this site

• A Study Evaluating the Efficacy and Safety of Giredestrant Combined With Palbociclib Compared With Letrozole Combined With Palbociclib in Participants With Estrogen Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer (persevERA Breast Cancer) — Running, not enrolling
• Study of Atezolizumab as Monotherapy and in Combination With Platinum-Based Chemotherapy in Participants With Untreated Locally Advanced or Metastatic Urothelial Carcinoma — Completed